441 related articles for article (PubMed ID: 29739748)
1. Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer.
Liu X; Pan B; Sun L; Chen X; Zeng K; Hu X; Xu T; Xu M; Wang S
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):746-754. PubMed ID: 29739748
[No Abstract] [Full Text] [Related]
2. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
4. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
[TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
6. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
8. Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma.
Sun L; Xu M; Zhang G; Dong L; Wu J; Wei C; Xu K; Zhang L
Int J Genomics; 2021; 2021():1326463. PubMed ID: 34988221
[TBL] [Abstract][Full Text] [Related]
9. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
10. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
[TBL] [Abstract][Full Text] [Related]
11. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
[TBL] [Abstract][Full Text] [Related]
12. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer.
Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L
Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318
[No Abstract] [Full Text] [Related]
13. Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
He T; Guo X; Li X; Liao C; Wang X; He K
J Oncol; 2021; 2021():5547911. PubMed ID: 33953745
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
15. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
19. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
